PUBLISHER: The Business Research Company | PRODUCT CODE: 1939304
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939304
Automated blood collection refers to the use of advanced systems that collect blood samples efficiently and precisely. These systems reduce manual handling, improve accuracy, minimize errors, and enhance patient comfort and safety, making them valuable in laboratories and healthcare facilities.
The primary categories in the automated blood collection market include arterial sampling, venipuncture sampling, and fingerstick sampling. Arterial sampling involves drawing blood from an artery, commonly the radial or femoral artery, to obtain samples for diagnostic purposes. The applications include diagnostics, treatment, and therapeutic procedures. The various end users include hospitals, diagnostic centers, pathology laboratories, and others.
Tariffs have influenced the automated blood collection market by increasing the cost of imported robotic and high-precision blood collection devices, affecting both production and end-user pricing. Segments such as robotic venipuncture systems and point-of-care fingerstick devices are most affected, with Asia-Pacific regions including China and India experiencing significant import duties. While tariffs increase operational costs, they also encourage local manufacturing, innovation in automation technologies, and development of cost-efficient domestic solutions.
The automated blood collection market research report is one of a series of new reports from The Business Research Company that provides automated blood collection market statistics, including automated blood collection industry global market size, regional shares, competitors with a automated blood collection market share, detailed automated blood collection market segments, market trends and opportunities, and any further data you may need to thrive in the automated blood collection industry. This automated blood collection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The automated blood collection market size has grown rapidly in recent years. It will grow from $1.52 billion in 2025 to $1.8 billion in 2026 at a compound annual growth rate (CAGR) of 18.1%. The growth in the historic period can be attributed to manual blood collection methods, reliance on conventional venipuncture, limited availability of automated systems, growing hospital and diagnostic center procedures, increasing demand for accurate diagnostics.
The automated blood collection market size is expected to see rapid growth in the next few years. It will grow to $3.46 billion in 2030 at a compound annual growth rate (CAGR) of 17.7%. The growth in the forecast period can be attributed to technological advancements in robotic venipuncture, rising adoption of point-of-care testing, increased investment in hospital automation, expansion of diagnostic centers and pathology laboratories, regulatory support for automated sample collection. Major trends in the forecast period include rising adoption of automated blood collection devices in hospitals, integration of robotic venipuncture and fingerstick systems, growing use of point-of-care blood collection solutions, increased focus on patient safety and comfort during sampling, expansion of high-precision diagnostics and therapeutic monitoring.
A notable increase in blood donation is expected to propel the growth of the automated blood collection market going forward. Blood donation is increasing due to multiple factors, including heightened awareness of the urgent need for blood in emergency medical situations, extensive blood donation campaigns organized by healthcare organizations and community groups, and advancements in medical technology that enhance the safety and efficiency of the donation process. Automated blood collection supports blood donation by streamlining operations and improving overall efficiency. It reduces the reliance on manual processes, thereby minimizing human error and donor discomfort. For instance, in 2024, NHS Blood and Transplant (NHSBT), a UK-based special health authority serving England and Wales, reported 119,371 new blood donations during the 2023-2024 period, reflecting a slight increase from 119,016 donations in 2022-2023. Therefore, the significant rise in blood donation is driving the growth of the automated blood collection market.
Leading companies operating in the automated blood collection market are developing innovative products incorporating advanced technologies, such as PentaPoint technology, to improve the precision and efficiency of blood collection. PentaPoint technology enables a more controlled and accurate blood collection process by using multiple entry points to reduce discomfort and enhance sample quality. For example, in April 2024, Becton, Dickinson, and Company, a US-based medical company, launched the BD Vacutainer UltraTouch push-button blood collection set in India and the US. This device is designed to minimize patient pain and discomfort during blood collection procedures. It integrates BD RightGauge technology, which uses a thinner needle, along with BD PentaPoint technology to significantly reduce insertion pain. Additionally, BD Push Button Technology lowers the risk of needle-stick injuries by 88%, improving both patient and clinician safety.
In January 2025, GVS S.p.A., an Italy-based manufacturer of filtration solutions for the healthcare and life sciences sectors, acquired Haemonetics' whole blood assets for $67.8 million. Through this acquisition, GVS seeks to broaden its product portfolio and strengthen its leadership in healthcare filtration by integrating proprietary whole blood collection, processing, and filtration solutions along with manufacturing facilities. Haemonetics is a US-based medical technology company that provides innovative blood and plasma collection, processing, and apheresis solutions aimed at improving patient outcomes and healthcare efficiency.
Major companies operating in the automated blood collection market are Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company, CSL Plasma, Quest Diagnostics Incorporated, B. Braun Melsungen AG, Fresenius KABI AG, Grifols S.A., Terumo Corporation, Nipro Medical Corporation, Greiner AG, Bio-Rad Laboratories Inc., ICU Medical Inc., Haemonetics Corporation, SARSTEDT AG & Co. KG, Owen Mumford Ltd., Retractable Technologies Inc., Macopharma, Chengdu Rich Science Industry Co. Ltd., Babson Diagnostics, Venibot
North America was the largest region in the automated blood collection market in 2025. The regions covered in the automated blood collection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the automated blood collection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The automated blood collection market consists of revenues earned by entities by providing services such as maintenance services, calibration, and technical support for their machines. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated blood collection market also includes sales of collection bags, needles, tubing sets, and reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Automated Blood Collection Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses automated blood collection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for automated blood collection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automated blood collection market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.